Schedule 13G ownership disclosure

Kitov Pharmaceuticals Holdings Ltd.

Security class unavailable · CUSIP: 49803V107

Event date: 2019-01-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,563,971
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-20-000224
Form type
SC 13G/A
Filer
Empery Asset Management, LP
CIK
CIK 1469336
Filed
Jan 15, 2020
Reporting period
Jan 16, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub